OBJECTIVE: To present the incremental cost from the payer's perspective and effectiveness of couples' family planning counseling (CFPC) with long-acting reversible contraception (LARC) access integrated with couples' voluntary HIV counseling and testing (CVCT) in Zambia. This integrated program is evaluated incremental to existing individual HIV counseling and testing and family planning services. DESIGN: Implementation and modelling. SETTING: Fifty-five government health facilities in Zambia. SUBJECTS: Patients in government health facilities. INTERVENTION: Community health workers and personnel promoted and delivered integrated CVCT+CFPC from March 2013 to September 2015. MAIN OUTCOME MEASURES: We report financial costs of actual expenditures during integrated program implementation and outcomes of CVCT+CFPC uptake and LARC uptake. We model primary outcomes of cost-per-: adult HIV infections averted by CVCT, unintended pregnancies averted by LARC, couple-years of protection against unintended pregnancy by LARC, and perinatal HIV infections averted by LARC. Costs and outcomes were discounted at 3% per year. RESULTS: Integrated program costs were $3 582 186 (2015 USD), 82 231 couples received CVCT+CFPC, and 56 409 women received LARC insertions. The program averted an estimated 7165 adult HIV infections at $384 per adult HIV infection averted over a 5-year time horizon. The program also averted 62 265 unintended pregnancies and was cost-saving for measures of cost-per-unintended pregnancy averted, cost-per-couple-year of protection against unintended pregnancy, and cost-per-perinatal HIV infection averted assuming 3 years of LARC use. CONCLUSION: Our intervention was cost-savings for CFPC outcomes and CVCT was effective and affordable in Zambia. Integrated couples-focused HIV and family planning was feasible, affordable, and leveraged HIV and unintended pregnancy prevention.
OBJECTIVE: To present the incremental cost from the payer's perspective and effectiveness of couples' family planning counseling (CFPC) with long-acting reversible contraception (LARC) access integrated with couples' voluntary HIV counseling and testing (CVCT) in Zambia. This integrated program is evaluated incremental to existing individual HIV counseling and testing and family planning services. DESIGN: Implementation and modelling. SETTING: Fifty-five government health facilities in Zambia. SUBJECTS: Patients in government health facilities. INTERVENTION: Community health workers and personnel promoted and delivered integrated CVCT+CFPC from March 2013 to September 2015. MAIN OUTCOME MEASURES: We report financial costs of actual expenditures during integrated program implementation and outcomes of CVCT+CFPC uptake and LARC uptake. We model primary outcomes of cost-per-: adult HIV infections averted by CVCT, unintended pregnancies averted by LARC, couple-years of protection against unintended pregnancy by LARC, and perinatal HIV infections averted by LARC. Costs and outcomes were discounted at 3% per year. RESULTS: Integrated program costs were $3 582 186 (2015 USD), 82 231 couples received CVCT+CFPC, and 56 409 women received LARC insertions. The program averted an estimated 7165 adult HIV infections at $384 per adult HIV infection averted over a 5-year time horizon. The program also averted 62 265 unintended pregnancies and was cost-saving for measures of cost-per-unintended pregnancy averted, cost-per-couple-year of protection against unintended pregnancy, and cost-per-perinatal HIV infection averted assuming 3 years of LARC use. CONCLUSION: Our intervention was cost-savings for CFPC outcomes and CVCT was effective and affordable in Zambia. Integrated couples-focused HIV and family planning was feasible, affordable, and leveraged HIV and unintended pregnancy prevention.
Authors: Susan Allen; Jareen Meinzen-Derr; Michele Kautzman; Isaac Zulu; Stanley Trask; Ulgen Fideli; Rosemary Musonda; Francis Kasolo; Feng Gao; Alan Haworth Journal: AIDS Date: 2003-03-28 Impact factor: 4.177
Authors: Kristin M Wall; William Kilembe; Bellington Vwalika; Lisa B Haddad; Shabir Lakhi; Udodirim Onwubiko; Naw Htee Khu; Ilene Brill; Roy Chavuma; Cheswa Vwalika; Lawrence Mwananyanda; Elwyn Chomba; Joseph Mulenga; Amanda Tichacek; Susan Allen Journal: Sex Transm Infect Date: 2017-01-12 Impact factor: 3.519
Authors: Leevan Tibaijuka; Robert Odongo; Emma Welikhe; Wilber Mukisa; Lilian Kugonza; Imelda Busingye; Phelomena Nabukalu; Joseph Ngonzi; Stephen B Asiimwe; Francis Bajunirwe Journal: BMC Womens Health Date: 2017-04-04 Impact factor: 2.809
Authors: April L Kelley; Ashley K Hagaman; Kristin M Wall; Etienne Karita; William Kilembe; Roger Bayingana; Amanda Tichacek; Michele Kautzman; Susan A Allen Journal: BMC Public Health Date: 2016-08-08 Impact factor: 3.295
Authors: Sergio Bautista-Arredondo; Sandra G Sosa-Rubí; Marjorie Opuni; David Contreras-Loya; Ada Kwan; Claire Chaumont; Abson Chompolola; Jeanine Condo; Omar Galárraga; Neil Martinson; Felix Masiye; Sabin Nsanzimana; Ivan Ochoa-Moreno; Richard Wamai; Joseph Wang'ombe Journal: AIDS Date: 2016-10-23 Impact factor: 4.177
Authors: Kristin M Wall; Mubiana Inambao; William Kilembe; Etienne Karita; Bellington Vwalika; Joseph Mulenga; Rachel Parker; Tyronza Sharkey; Divya Sonti; Amanda Tichacek; Eric Hunter; Robert Yohnka; Joseph F Abdallah; Ibou Thior; Julie Pulerwitz; Susan Allen Journal: Int J Epidemiol Date: 2019-02-01 Impact factor: 7.196